Demo Data from EDBT 2026 / reviewers in the wild / expert
David W. Bednarski
dblp:01/97
· DBLP profile ↗
1ranked-venue papers
0as first author
0since 2021 · last 2000
—ORCID · none
Domains — the database's venue-derived domains; a paper can count in several
Applied, interdisciplinary, general and emerging computing · 1
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
1 paper |
Bioinformatics and computational biology · 100% |
Topics — the 3 heaviest of 3, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology › computational oncology
cancer classification from gene expression |
0.0 | 1 | 2000 | Support vector machine classification and validation of cancer tissue samples using microarray expression data · Bioinform. 2000 |
Bioinformatics and computational biology
feature selection |
0.0 | 1 | 2000 | Support vector machine classification and validation of cancer tissue samples using microarray expression data · Bioinform. 2000 |
Bioinformatics and computational biology
gene expression analysis |
0.0 | 1 | 2000 | Support vector machine classification and validation of cancer tissue samples using microarray expression data · Bioinform. 2000 |
Methods — techniques the papers use, named apart from their topics
support vector machine · 0.0machine learning classification · 0.0
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2000 | Support vector machine classification and validation of cancer tissue samples using microarray expression dataabstractMOTIVATION: DNA microarray experiments generating thousands of gene expression measurements, are being used to gather information from tissue and cell samples regarding gene expression differences that will be useful in diagnosing disease. We have developed a new method to analyse this kind of data using support vector machines (SVMs). This analysis consists of both classification of the tissue samples, and an exploration of the data for mis-labeled or questionable tissue results. RESULTS: We demonstrate the method in detail on samples consisting of ovarian cancer tissues, normal ovarian tissues, and other normal tissues. The dataset consists of expression experiment results for 97,802 cDNAs for each tissue. As a result of computational analysis, a tissue sample is discovered and confirmed to be wrongly labeled. Upon correction of this mistake and the removal of an outlier, perfect classification of tissues is achieved, but not with high confidence. We identify and analyse a subset of genes from the ovarian dataset whose expression is highly differentiated between the types of tissues. To show robustness of the SVM method, two previously published datasets from other types of tissues or cells are analysed. The results are comparable to those previously obtained. We show that other machine learning methods also perform comparably to the SVM on many of those datasets. AVAILABILITY: The SVM software is available at http://www.cs. columbia.edu/ approximately bgrundy/svm. Terrence S. Furey, Nello Cristianini, Nigel Duffy, David W. Bednarski, Michèl Schummer, David Haussler |
Bioinform. | 4 |